Publications by authors named "E URIAS"
Purpose: The purpose of this study was to report the visual and anatomic results at 12 and 24 months using the protocol of 3 monthly (PRN) injections for diabetic macular edema (DME).
Methods: This was a retrospective chart review of 97 eyes with DME treated with a protocol of cycles consisting of 3 monthly injections of anti-vascular endothelial growth factor drugs on a PRN basis. Change in visual acuity was the main outcome measure.
Background: In patients with metabolic dysfunction-associated steatotic liver disease (MASLD), there are limited data on how changes in FIB4 and liver stiffness measurement (LSM) correlate in non-biopsy cohorts.
Aims: Our objective was to evaluate associations between changes in FIB4 and LSM in MASLD patients.
Methods: We included MASLD patients with serial VCTE from 2015-2022.
Article Synopsis
- - This study evaluated the effectiveness of various liver stiffness measurement (LSM) scores, including AGILE3 + and AGILE4, in predicting liver-related events in patients with nonalcoholic fatty liver disease (NAFLD), particularly focusing on those with diabetes and obesity.
- - Data was analyzed from 1903 adult NAFLD patients who underwent vibration-controlled transient elastography (VCTE) over seven years, with a total of 25 liver-related events recorded.
- - Results showed that AGILE3 + and AGILE4 scores significantly outperformed LSM and FAST scores in predicting liver-related events, especially in individuals with diabetes and obesity, highlighting their potential for better risk stratification in
Background: The PNPLA3-rs738409-G, TM6SF2-rs58542926-T, and HSD17B13-rs6834314-A polymorphisms have been associated with cirrhosis, hepatic decompensation, and HCC. However, whether they remain associated with HCC and decompensation in people who already have cirrhosis remains unclear, which limits the clinical utility of genetics in risk stratification as HCC is uncommon in the absence of cirrhosis. We aimed to characterize the effects of PNPLA3, TM6SF2, and HSD17B13 genotype on hepatic decompensation, HCC, and liver-related mortality or liver transplant in patients with baseline compensated cirrhosis.
View Article and Find Full Text PDFIntroduction: Esophageal squamous cell carcinoma (ESCC) has a higher incidence and prevalence than esophageal adenocarcinoma among Black individuals in the United States. Black individuals have lower ESCC survival. These racial disparities have not been thoroughly investigated.
View Article and Find Full Text PDF